China · Delayed Price · Currency is CNY Sichuan Huiyu Pharmaceutical Company Description
Sichuan Huiyu Pharmaceutical Co., Ltd. research and develops, produces, and sells anti-tumor injection in China and internationally.
The company offers injection drug products, such as pemetrexed disodium, methrotraxate, docetaxel, azacitidine, oxaliplatin, cyclophosphamide, irinotecan hydrochloride, paclitaxel, bendamustine hydrochloride, decitabine, palonosetron hydrochloride, plerixafor, levetiracetam concentrated solution, amifostine, levofolate calcium, thiotepa, fulvestrant, and milrinone drugs.
It also offers moroxydine sodium chloride, fluorouracil, sodium thiosulfate, acetylcysteine, nimodipine, nimodipine, dihydroxypropyltheophylline, cisatracurium besylate, cladribine, sodium carbosulfan, octreotide acetate, mesobamo, doxorubicin, leucovorin calcium, panosetron hydrochloride, famotidine, etoposide, polymyxin B sulfate, melphalan hydrochloride, thiotepa, teicoplanin, epirubicin hydrochloride, methotrexate, gemcitabine hydrochloride, cytarabine, voriconazole, roxatidine acetate hydrochloride, and bortezomib drugs.
Sichuan Huiyu Pharmaceutical Co., Ltd. was incorportaed in 2010 and is headquartered in Neijiang, China.
| Country | China |
| Founded | 2010 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,331 |
| CEO | Zhao Ding |
Contact Details
Address: Building 3 Neijiang, 641000 China | |
| Phone | 86 83 2880 8001 |
| Website | huiyupharma.com |
Stock Details
| Ticker Symbol | 688553 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100004ZT4 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Zhao Ding | Chairman of the Board and GM |
| Lan Gao | Director and Finance Director |
| Yan Mei Yu | Accounting Supervisor |
| Chun Ping Zhang | Deputy GM and Secretary of the Board |
| Gang Cai | Manager of Technical Department, Quality Manager and Quality Director |
| Dr. He Ping Hu | Vice President of Pharmaceutical Research Institute |
| Dr. Tao Wei | Vice President of Pharmaceutical Research Institute |
| Yong Chun Ren | Deputy General Manager |
| Dr. Shou Jun Chen | Vice President of Pharmaceutical Research Institute |